Authors


ANGELIKI MESSINA, MSPHARM, BSPHARM

Latest:

Globalization of Antibiotic Stewardship Programs: The World Is Waiting

The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.


Susie Lee, PharmD (student)

Latest:

New Flucelvax Quadrivalent Influenza Vaccine Approved by FDA

Sequirus recently announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent influenza vaccine.


Ryan W. Stevens, PharmD, BCPS, BCIDP*

Latest:

Maximize Contact and Minimize Isolation

Optimizing the relationship between infection prevention and antimicrobial stewardship.


Nicola M. Parry, BVSc, MRCVS, MSc, DACVP, ELS

Latest:

Study Identifies Risk Factors for Vascular Graft Infections

Vascular graft infections are serious complications of reconstructive vascular surgery that may increase patients’ morbidity and mortality.


Laurel J. Glaser, MD, PhD

Latest:

An Unusual Case of Testicular Swelling in a Patient With HIV

Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.


BRAYDEN SCHINDELL

Latest:

What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental Countermeasures

How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?


Ellie J.C. Goldstein, MD, FIDSA, FSHEA

Latest:

Investigational Treatments for Clostridioides difficile Infection

The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.


JENNIFER BAILEY, PHARMD, BCPS, AAHIVP

Latest:

Exploring the Threat of MDR-TB in the United States

The virulent pathogen has significant individual and public health implications.


Anneka Hutton, MD

Latest:

Pulmonary Coinfection With C neoformans and C immitis: A Novel Fungal Cohabitation

A patient presented with a history of uncontrolled HIV and a history of polysubstance use.


Samuel L. Aitken, PharmD, MPH, BCIDP

Latest:

NDM-Producing E coli Harboring PBP Insert Variants Emerges as New Threat

As with other metallo-β-lactamases, NDM is capable of hydrolyzing nearly all β-lactams, including carbapenems, and the search for the proper antimicrobials is challenging.


Umida Nasritdinova, PharmD Candidate

Latest:

Vaginal Microbiome Transplantation Effective in Intractable Bacterial Vaginosis

A recent study reported the benefit of vaginal microbiome transplantation for the treatment of recurrent bacterial vaginosis.


NIHAAL KARNIK, MD

Latest:

Salt, Ticks, and Lyme: A Case of Lyme Neuroborreliosis Presenting as SIADH

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).


Emily Heil, PharmD, BCPS-AQ ID, Monica Mahoney, PharmD, BCPS-AQ ID

Latest:

The Ultimate Infectious Disease Pharmacist Holiday Wish List

In case you were wondering what to get the infectious disease (ID) pharmacist in your life for the upcoming holidays.


Thelma King Thiel, RN, BA

Latest:

With October Being Liver Awareness Month, an Opportunity to Acknowledge This Essential Organ

It is important to recognize this organ that has multiple life-enhancing functions.


LAURI HICKS, DO

Latest:

Managing Reluctant Antibiotic Stewards: Advice From an ID Physician and an ID Pharmacist

Although challenging, it is not impossible to change some outlier behaviors.



MARY BETTE FORTE, MSN-ED, RN

Latest:

Actively Involving Nurses in Antibiotic Stewardship

Staff nurses are underused but potentially valuable contributors to antibiotic stewardship.


Kevin Kunzmann

Latest:

What Can the United States Learn from India's Hepatitis C Eradication Model?

Madhumita Premkumar, MD, discusses a nationwide, cost-efficient eradication strategy she believes could benefit Americans' efforts to curb HCV.


Jason Harris

Latest:

Investigators Find Large Survival Disparities Among Patients with HPV-Associated Cancers

A recent study finds that younger patients, women, and white individuals infected with HPV-associated cancers have superior survival at 5 years.




THOMAS P. LODISE, PHARMD, PHD*

Latest:

Two More Agents Bolster the Arsenal Against Gram-Negative Resistance

As the antibiotic pipeline produces new therapies, clinicians must understand each agent’s specific role in manage­ment of patients infected by multidrug-resistant pathogens.


Maria Heaney, PharmD

Latest:

A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt Infection

Rare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.


SARA ALOSAIMY, PHARMD, BCPS

Latest:

Eravacycline: The IGNITE Growth of the Tetracyclines

The synthetic novel tetracycline offers a new option for complicated intra-abdominal infections.


Christian Y. Cho, PharmD

Latest:

Duration of Antibiotic Therapy for Uncomplicated Gram-Negative Bacteremia: Seven Is the New Fourteen

The treatment duration for uncomplicated gram-negative bloodstream infections (BSIs) has traditionally ranged from 7 to 14 days. However, recent retrospective studies and meta-analyses have observed no differences in clinical outcomes in patients treated with shorter courses compared with prolonged courses, especially with urinary sources of infection.


CEO

Latest:

Reassessing Practices Is Critical During an Infectious Disease Outbreak

The constant reassessment of business practices is necessary to ensure that practitioners are not wasting valuable time, resources, and effort on activities that are not producing the desired results.


Kylie Pritchard, PharmD, BCPS-AQ ID

Latest:

Lessons From the MERINO Trial

Is the use of piperacillin/tazobactam for bacteremia caused by ceftriaxone-nonsusceptible Escherichia coli and Klebsiella pneumoniae an obsolete practice?


Alvaro Toledo, PhD

Latest:

Tick, Tick, Tick: Vector-Borne Diseases Ramp Up

Infections transmitted by these bloodsucking species are on the rise worldwide.


Daniel Holland, PharmD

Latest:

Assessing Statin Use in HIV-Positive Patients Taking Protease Inhibitors

A recent study takes a closer look at statin use in HIV-positive patients who are taking protease inhibitors.


© 2025 MJH Life Sciences

All rights reserved.